Korean Stock
PERI
Jeil Pharmaceutical
★
Q1 Consolidated Revenue Down 20%, Operating Profit Plunges 93%... Treasury Shares Fully Sold
 05/18/2026, 05:11 PM
PERI
Jeil Pharmaceutical
★
Jeil Pharma Q1 2026: Consol. Revenue -20%, Op. Profit -93%; Subsidiary Oncovic Strong
 05/15/2026, 05:06 PM
OWNR
Jeil Pharmaceutical
★
Submission of Major Shareholding Report (No Holdings Data)
 05/03/2026, 07:00 AM